Mark Houston, MD, MS, MSc, ABAARM, FACP, FAHA, FASH, FACN, FAARM
Director, Hypertension Institute and Vascular Biology
Saint Thomas West Hospital
For more information about Dr. Houston, please visit:
Estimated time of Talk
45 min webcast = 0.75 credits
15 min Q&A = 0.25 credits
Total = 1.0 credits
- Understand the pathogenesis of hypertension and Endothelial Dysfunction
- Review the role of vascular biology, three finite vascular responses (inflammation, oxidative stress and vascular immune function), plasma renin activity (PRA) and aldosterone to select optimal integrative anti-hypertensive therapy to reduce BP and decrease CVD.
- Review the role of Nitric Oxide, ADMA and SDMA in hypertension and CVD
- Review diagnostic testing for hypertension: 24 hour ambulatory BP (ABM), endothelial function and arterial compliance testing.
- Be able to prioritize and personalize the most important nutritional, nutraceutical supplements and life style treatments for hypertension
Conflicts of Interest
Dr. Houston is an independent contractor/consultant for Biotics Research, Spectracell, Designs for Health, Thorne, Vibrant America Labs, Cleveland HeartLab and AC Grace and he is on the review panel/board for Designs for Health, Thorne, Boston Heart Lab, Itamar and receives grants from private industry from Biotics, Thorne and Neogenis.
This enduring material activity, New Concepts in the Diagnosis and Treatment of Hypertension: The Role of Endothelial Function, Vascular Biology, Nitric Oxide, ADMA and SDMA, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins October 4, 2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.